The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis.
Lu M, Zhang J, Li M, Ge X, Dai X, Zhao J, Fu M, Wang T, Fang X, Li C, Zhang R, Zhao W, Zheng T, Wang F, Yu M, Lei T, Wang N, Bao Y, Liu L, Liu Y, Jia W.
Lu M, et al. Among authors: yu m.
Mol Cell Biochem. 2016 Nov;422(1-2):181-188. doi: 10.1007/s11010-016-2819-6. Epub 2016 Sep 16.
Mol Cell Biochem. 2016.
PMID: 27633502
Clinical Trial.